US2023340654A1PendingUtilityA1
Method for manufacturing a biocompatible wire
Assignee: HERAEUS DEUTSCHLAND GMBH & CO KGPriority: Jan 22, 2020Filed: Jun 23, 2023Published: Oct 26, 2023
Est. expiryJan 22, 2040(~13.5 yrs left)· nominal 20-yr term from priority
C22F 1/10C21D 1/26C21D 8/06C22C 19/05C22C 19/07B21F 45/008B21C 1/003C21D 9/525C22C 27/04B21C 9/00C22C 30/00C22C 19/00C22C 19/055C22C 19/056C22F 1/00
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The disclosure relates to a method for manufacturing a biocompatible wire, a biocompatible wire comprising a biocompatible metallic material and a medical device comprising such wire. The method for manufacturing a biocompatible wire comprises providing a workpiece of a biocompatible metallic material, cold working the workpiece into a wire, and annealing the wire, wherein a cold work percentage is 97 to 99%, wherein the cold working is a drawing with a die reduction per pass ratio in a range of 6 to 40%, and wherein the annealing is done in a range of 850 to 1100° C.
Claims
exact text as granted — not AI-modified1 . A biocompatible wire comprising a biocompatible metallic material, which is cold worked from a workpiece and annealed,
wherein a cold work percentage is 97 to 99%, wherein the cold working is a drawing with a die reduction per pass ratio in a range of 6 to 40 %, and wherein the annealing is done in a range of 850 to 1100° C. wherein the wire comprises grains with a mean grain size in a range of 20 to 1000 nm.
2 . The wire according to claim 1 , wherein the wire has a yield strength in a range of 1300 to 1900 MPa.
3 . The wire according to claim 1 , wherein the wire has an ultimate tensile strength in a range of 1700 to 2400 MPa.
4 . The wire according to claim 1 , wherein the wire has an essentially uniform grain size distribution along a cross section of the wire.
5 . The wire according to claim 1 , wherein the biocompatible metallic material is an alloy comprising the following components:
Cr in a range from about 10 to about 30 wt. %; Ni in a range from about 20 to about 50 wt. %; Mo in a range from about 2 to about 20 wt. %; Co in a range from about 10 to about 50 wt. %, wherein the Cr, Ni, Mo and Co components are major constituents of the alloy with at least about 95 wt. % of the alloy being Cr, Ni, Mo and Co.
6 . The wire according to claim 5 , wherein the biocompatible metallic material further comprises an additional material comprising at least one of a group of Silver, Platinum, Tantalum, Gold, Copper and alloys thereof.
7 . The wire according to claim 6 , wherein the Cr, Ni, Mo and Co alloy forms a core and the additional material forms a shell around the core when the wire is seen in a cross section.
8 . The wire according to claim 6 , wherein the additional material forms a core and the Cr, Ni, Mo and Co alloy forms a shell around the core when the wire is seen in a cross section.
9 . The wire according to claim 1 , wherein the drawing is a full die drawing.
10 . The wire according to claim 1 , wherein the drawing is done with a deformation factor in a range of 1.2 to 2.0 and a contact length between the workpiece and a drawing tool is in a range of 0.5 to 0.2 mm.
11 . The wire according to claim 1 , wherein the drawing is done with a speed in a range of 15 to 150 m/min.
12 . The wire according to claim 1 , wherein an initial diameter of the workpiece before drawing is in a range of 3 to 5 mm.
13 . The wire according to claim 1 , wherein a diameter of the wire after drawing is in a range of 0.1 to 0.9 mm.
14 . The wire according to claim 1 , wherein the annealing is done for 750 to 1500 seconds.
15 . The wire according to claim 1 , wherein the annealing is followed by an additional drawing with a cold working percentage of 95 to 97%.
16 . A medical device, comprising a wire according to claim 1 , as a lead.Join the waitlist — get patent alerts
Track US2023340654A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.